Perioperative characteristics | Leiomyoma (N = 35) | Uterine cancer (N = 53) |
---|---|---|
Robotic platform | 26 (74.3) | 34 (64.2) |
Uterine weight (grams)a | 448.35 ± 194.9 [range 140–1076] | 321.77 ± 102.1 [range 135–611] |
Intra-op size estimate (weeks)b | 14.8 ± 2.6 [range 10–20] | 12.5 ± 2.2 [range 6–16] |
Operative time (minutes)c | 206.0 ± 76.3 [range 115–391] | 237.5 ± 67.0 [range 131–399] |
Abdominal/pelvic Adhesions | 13 (37.1) | 35 (34.0) |
Length of stayd | 0.97 ± 0.5 [range 0–3] | 1.12 ± 0.4 [range 0–3] |
Mode of morcellation | ||
Port site | 3 (8.6) | 0 (0) |
Vaginal | 29 (82.9) | 52 (98.1) |
Other | 3 (8.6) | 1 (1.9) |
Post-op Diagnosis | ||
Leiomyoma | 35 (100) | 40 (75.5) |
Endometrial cancere | 1 (2.9) | 53 (100) |
Benign ovarian neoplasm | 9 (25.7) | 6 (11.3) |
Adenomyosis | 13 (37.1) | 18 (33.9) |
Pelvic adhesive disease | 8 (22.9) | 9 (17.0) |
Otherf | 18 (51.4) | 12 (22.6) |
Post-op complicationsg | 3 (8.6) | 4 (7.5) |
Length of follow-up (months) | 31 ± 21 [range 3–89] | 24 ± 21 [range 1–85] |